Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Mar 28, 2022

Keywords

ClinConnect Summary

The TeKnO T1D trial is a study designed to help parents of children aged 8 to 12 who have type 1 diabetes (T1D). The goal is to find out what information and support these parents need to better use insulin pumps and continuous glucose monitors (CGM) for managing their child's diabetes. Based on this information, researchers plan to create a helpful app that provides education and resources to improve diabetes management and health outcomes for kids using these technologies.

To be eligible for this study, your child must be between 8 and 12 years old, diagnosed with T1D for at least six months, and currently using an insulin pump and CGM. Additionally, a parent or primary caregiver will need to participate and be fluent in English. If you decide to join the study, you can expect to share your experiences and needs as a parent, which will guide the development of the app. It's important to note that the study is not yet recruiting participants, so you'll need to wait for more information if you are interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. child 8-12 years of age with a diagnosis of T1D ≥ 6 months
• • 2. currently using insulin pump( IP) and CGM ≥ 1 month \[including Hybrid Closed Loop (HCL) systems\]
• • 3. participation of primary diabetes caregiver
• • 4. English fluency
• • 5. mean A1c \>7.5% over the past 6 months (Aim 3 only)
• Exclusion Criteria:
• • 1. major illnesses other than T1D in the child
• • 2. significant cognitive limitations or major psychiatric disorders in the child or parent
• • 3. the use of medications other than insulin to control blood glucose levels.